Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years.
about
Biologics in asthma--the next step toward personalized treatmentOmalizumab: clinical use for the management of asthma.Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust.Impact of omalizumab on medical cost of childhood asthma in Japan.
P2860
Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@ast
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@en
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@nl
type
label
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@ast
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@en
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@nl
prefLabel
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@ast
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@en
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@nl
P2093
P3181
P356
P1476
Omalizumab for the treatment o ...... a in children aged 6-11 years.
@en
P2093
P3181
P356
10.3310/HTA15SUPPL1/02
P478
15 Suppl 1
P577
2011-05-01T00:00:00Z